Efficacy and safety of new direct oral anticoagulants in chronic kidney disease: AHA 2019 updated guidelines and review of the literature

• Main Authors: Hubert Stępak (Author), Zbigniew Krasiński (Author), Andrzej Jawień (Author), Navid Ahmadi (Author), Adam Lipowski (Author), Michał Stanisic (Author)
• Format: Book
• Published: Termedia Publishing House, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Direct oral anticoagulants (DOACs) are the drug of choice for the treatment of atrial fibrillation-associated systemic embolism and reducing the risk of strokes in chronic kidney disease (CKD) patients. DOACs have fewer drug-to-drug interactions as well as fewer side effects, compared to warfarin. T...